BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34695177)

  • 21. Upregulation of Long Noncoding RNA GAS5 Inhibits Lung Cancer Cell Proliferation and Metastasis via miR-205/PTEN Axis.
    Dong L; Li G; Li Y; Zhu Z
    Med Sci Monit; 2019 Mar; 25():2311-2319. PubMed ID: 30926767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA-HOTAIR activates autophagy and promotes the imatinib resistance of gastrointestinal stromal tumor cells through a mechanism involving the miR-130a/ATG2B pathway.
    Zhang J; Chen K; Tang Y; Luan X; Zheng X; Lu X; Mao J; Hu L; Zhang S; Zhang X; Chen W
    Cell Death Dis; 2021 Apr; 12(4):367. PubMed ID: 33824300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of long noncoding RNA MINCR promotes non-small cell of lung cancer growth by negatively regulating miR-126/SLC7A5 axis.
    Wang J; Ding M; Zhu H; Cao Y; Zhao W
    Biochem Biophys Res Commun; 2019 Jan; 508(3):780-784. PubMed ID: 30528230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer.
    Yuan S; Xiang Y; Wang G; Zhou M; Meng G; Liu Q; Hu Z; Li C; Xie W; Wu N; Wu L; Cai T; Ma X; Zhang Y; Yu Z; Bai L; Li Y
    Mol Oncol; 2019 Apr; 13(4):840-856. PubMed ID: 30614188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
    Huang Q; Xing S; Peng A; Yu Z
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis.
    An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ
    Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.
    Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X
    Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
    Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
    Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
    Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y
    Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
    Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
    Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA PCGsEM1 Contributes to the Proliferation, Migration and Invasion of Non-small Cell Lung Cancer Cells via acting as a Sponge for miR-152-3p.
    Huang J; Lou J; Liu X; Xie Y
    Curr Pharm Des; 2021; 27(46):4663-4670. PubMed ID: 34455968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L; Chen Y; Li Q; Duan P
    J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer.
    Shen Q; Xu Z; Xu S
    Int J Oncol; 2020 Oct; 57(4):967-979. PubMed ID: 32945379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
    Qi G; Li L
    Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer.
    Li H; Liu J; Cao W; Xiao X; Liang L; Liu-Smith F; Wang W; Liu H; Zhou P; Ouyang R; Yuan Z; Liu J; Ye M; Zhang B
    Theranostics; 2019; 9(18):5134-5148. PubMed ID: 31410206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.